Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Bruchim

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|October 12, 2012
Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2Sharon Cohen, Ilan Bruchim, Dror Graiver, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2025
Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomesAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 20, 2023
Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Gynecologic Oncology|June 26, 2021
Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational studyTamar Safra, Barliz Waissengrin, Deanna Gerber, et al.
Gynecologic Oncology Reports|April 26, 2022
Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group StudyYoav Brezinov, Tamar Katzir, Ofer Gemer, et al.
Journal of Gynecology Obstetrics and Human Reproduction|August 30, 2022
Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group studyOhad Houri, Yotam Gil, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group studyOri Tal, Ram Eitan, Ofer Gemer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 20, 2021
Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective studyTamar Perri, Gabriel Levin, Limor Helpman, et al.
Surgical Oncology|September 6, 2020
Is the extent of pelvic lymphadenectomy in the staging of endometrial cancer associated with the yield of metastatic nodes? An Israeli Gynecologic Oncology Group studyMisgav Rottenstreich, Ofer Gemer, Limor Helpman, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of Molecular Medicine (Berlin, Germany)|October 12, 2012
Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2Sharon Cohen, Ilan Bruchim, Dror Graiver, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2025
Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomesAhmet Namazov, Limor Helpman, Ram Eitan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 20, 2023
Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Gynecologic Oncology|June 26, 2021
Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational studyTamar Safra, Barliz Waissengrin, Deanna Gerber, et al.
Gynecologic Oncology Reports|April 26, 2022
Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group StudyYoav Brezinov, Tamar Katzir, Ofer Gemer, et al.
Journal of Gynecology Obstetrics and Human Reproduction|August 30, 2022
Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group studyOhad Houri, Yotam Gil, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group studyOri Tal, Ram Eitan, Ofer Gemer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 20, 2021
Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective studyTamar Perri, Gabriel Levin, Limor Helpman, et al.
Surgical Oncology|September 6, 2020
Is the extent of pelvic lymphadenectomy in the staging of endometrial cancer associated with the yield of metastatic nodes? An Israeli Gynecologic Oncology Group studyMisgav Rottenstreich, Ofer Gemer, Limor Helpman, et al.
Pageof 9